Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127710721 | 12771072 | 1 | I | 20160623 | 20160914 | 20160922 | 20160922 | EXP | IT-ELI_LILLY_AND_COMPANY-IT201609005307 | ELI LILLY AND CO | 71.21 | YR | F | Y | 0.00000 | 20160921 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127710721 | 12771072 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | UNK, UNKNOWN | 20592 | TABLET | |||||||||
| 127710721 | 12771072 | 2 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | 25 MG, UNKNOWN | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127710721 | 12771072 | 1 | Senile dementia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127710721 | 12771072 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127710721 | 12771072 | Delirium | |
| 127710721 | 12771072 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |